Pharmaron Beijing (03759) appoints Luo Bailiang as an executive director of the fourth board of directors.
Kanglong Chemical (03759) announced that at the annual general meeting, following the election by attending shareholders, it was resolved to appoint Dr. Lou Bailiang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei as executive directors of the fourth board of directors, appoint Ms. Wan Xuan as a non-executive director of the fourth board of directors, and appoint Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong as independent non-executive directors of the fourth board of directors.
Pharmaron Beijing (03759) announced that at the annual shareholder meeting, after election and resolution by attending shareholders, it was approved to appoint Dr. Lou Bailiang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei as executive directors of the fourth board of directors, appoint Ms. Wan Xuan as a non-executive director of the fourth board of directors, and appoint Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong as independent non-executive directors of the fourth board of directors.
Related Articles
US Stock Market Move | SpaceX went public today! Space-related stocks collectively fell, with Virgin Galactic (SPCE.US) dropping by 24%.
BANKOFJIUJIANG (06190) will distribute a final dividend of 0.56 yuan per 10 shares on July 3rd.
YNBY INTL (00030) spent HK$89,500 on June 12 to repurchase 420,000 shares.
US Stock Market Move | SpaceX went public today! Space-related stocks collectively fell, with Virgin Galactic (SPCE.US) dropping by 24%.
BANKOFJIUJIANG (06190) will distribute a final dividend of 0.56 yuan per 10 shares on July 3rd.
YNBY INTL (00030) spent HK$89,500 on June 12 to repurchase 420,000 shares.
RECOMMEND
